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Prevalence and Co-Existance of Diabetes with HIV and Hcv
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A. Janbakhsh ∗, F. Mansouri, S. Vaziri, B. Sayyad, M.
Afsharian, S.S. Meigouni
Kermanshah university of medical science, kermanshah,
Iran (Islamic Republic of)
Background: Diabetes Mellitus (DM) comprises a group
of common metabolic disorders that share the pheno-
type of hyperglycemia. Increasing age, family history, race,
obesity, hypertension, and history of vascular disease are
known predisposing factors for diabetes. It seems that
chronic hepatitis C and HIV/HCV co-infection and anti-
retroviral treatment (ART) especially regimen contains
protease inhibitors may predispose to diabetes. Regard to
more prevalence of diabetes in HCV infected patients in
other studies and also increasing number of HIV infected
cases and HIV infected patients treating with antiretroviral
drugs in the country and importance of early diagnosis and
control of chronic disease in these patients, this study was
conducted to determine prevalence of diabetes in patients
with HIV and HCV infection.
Methods: In this descriptive cross-sectional study, the
registries of 150 HCV patients and 50 HIV patients and
90HIV/HCV co-infected patients in hepatic clinics and
consulting center for behavioral disorders of Kermanshah
University of Medical Science in 2007 which selected by con-
venience sampling, were studied. Data of age, sex, duration
of disease, history of injection drug user (IDU), liver enzymes
level, CD4 count, ART, treatment with interferon (IFN), and
blood sugar level were collected. If they had two fast blood
sugar (FBS) ≥126 or random blood sugar (BS) ≥200 were
described diabetic. The data analyzed by SPSS software with
chi-square, Fisher and Z tests
Results: The prevalence of diabetes was 2.7% among
patients infected with HCV, and 4% in patients infected with
HIV and 2.2% in patients co-infected with HIV/HCV. None of
the variables including age, sex, liver enzyme, injecting drug
usage, CD4 count, antiretroviral treatment, and interferon
were determined as risk factors for diabetes.
Conclusion: Although we didn’t ﬁnd any signiﬁcant cor-
relation between HIV and HCV infection and HIV/HCV
co-infection with increasing risk of diabetes, but accord-
ing to previous studies and incomplete information about
some diabetes risk factors in our registries such as BMI,
staging of cirrhosis, HCV viral load and nutrional status of
HIV infected cases and exclusion of subjects with only one
abnormal FBS from our samples, we recommended regu-
lar measurement of FBS for HIV, HCV infected and HIV/HCV
co-infected patients and designing supplement studies con-
sidering these risk factors. Key Worlds: HIV, HCV, Diabetes,
Kermanshah
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Unusual Cutaneous Infections in HIV
B. Mehta ∗, M. Dhingra, S. Amladi, C. Nayak, S. Savant
B.Y.L. Nair Charitable Hospital and T.N.Medical College,
Mumbai, India
We discuss four unusual cutaneous infections in HIV pos-
itive patients.
Case 1: A 45 year old female presented with complaints
of multiple ulcers with foul smelling discharge in perigen-
ital region since 1 month. There was history of recurrent
fever, diarrhoea and weight loss since 1 year, past her-
pes zoster and abdominal tuberculosis. On examination
there were multiple round to oval, deep ulcers with under-
mined edge and thick yellowish slough in the perigenital
region and on the buttocks. CD4 counts was 173. Pus swab
grew Staphylococcus aureus. Edge biopsy from the ulcer
showed presence of gram positive cocci in clusters; PAS
stain showed Michaelis-Gutmann inclusion bodies conﬁrm-
ing the rare presentation of cutaneous MALAKOPLAKIA due
to Staphylococcus aureus. She was treated with intravenous
antibiotics with complete healing of ulcers.
Case 2: A 30 year old male presented with multiple red
raised painful lesions on face, trunk and extremities asso-
ciated with pain 1 month after starting 3 drug ART (d4T +
3TC+NVP). Sensory loss, multiple nerve thickening, edema
of the feet and knee joints, along with biopsy ﬁndings,
indicated Type I reaction in Tuberculoid leprosy. CD4 count
at start of ART was 162, and increased to 264, indicating
Immune Reconstitution Inﬂammatory response (IRIS). This
was a rare presentation of reaction in leprosy as a mani-
festation of IRIS. The patient responded well to multidrug
therapy.
Case 3: A 33 year old male acutely developed multiple
large pus ﬁlled ulcerated lesions since 15-20 days with-
out pain and constitutional symptoms. He had multiple
large carbunculoid ulcers on nape of neck, chest and upper
extremities, which grew S.aureus. CD4 count was 127. The
unusual presentation led to detection of HIV in this patient.
Patient responded to iv antibiotics.
Case 4: A 60 year old male presented with 10 days history
of multiple, painful, oozing lesions over both hands and feet
associated with swelling of hands and feet. He had tender,
tense haemorrhagic bullae and multiple erosions with cen-
tral eschar distributed over dorsae of hands, extensors of
forearms and elbows, dorsal aspect of right foot and lateral
aspect of right leg. CD4 count of 18. Pus swabs grew E.coli.
A ﬁnal diagnosis of Echthyma gangrenosum was reached.
Despite appropriate therapy, he succumbed to death due
to septicemia.
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